Mezzion Pharma Co.,Ltd. (KOSDAQ:140410)

Mezzion Pharma Revenue

Mezzion Pharma had revenue of 2.02B KRW in the quarter ending March 31, 2026, with 3.19% growth. This brings the company's revenue in the last twelve months to 7.97B, down -5.18% year-over-year. In the year 2025, Mezzion Pharma had annual revenue of 7.91B, down -8.15%.

• Revenue (ttm): 7.97B
• Revenue Growth: -5.18%
• P/S Ratio: 211.97
• Revenue / Employee: 442.88M
• Employees: 18
• Market Cap: 1.69T

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	7.91B	-702.12M	-8.15%
Dec 31, 2024	8.61B	-23.11B	-72.85%
Dec 31, 2023	31.72B	994.76M	3.24%
Dec 31, 2022	30.73B	4.07B	15.28%
Dec 31, 2021	26.65B	-1.98B	-6.92%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 26, 2026

Data Sources Report a data error